Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Total Debt: 2017-2024

Historic Total Debt for Organogenesis Holdings (ORGO) over the last 6 years, with Sep 2024 value amounting to $62.1 million.

  • Organogenesis Holdings' Total Debt fell 8.11% to $62.1 million in Q3 2024 from the same period last year, while for Sep 2024 it was $256.7 million, marking a year-over-year decrease of 7.40%. This contributed to the annual value of $66.2 million for FY2023, which is 6.41% down from last year.
  • Organogenesis Holdings' Total Debt amounted to $62.1 million in Q3 2024, which was down 2.16% from $63.5 million recorded in Q2 2024.
  • Organogenesis Holdings' Total Debt's 5-year high stood at $76.7 million during Q1 2022, with a 5-year trough of $59.6 million in Q1 2020.
  • Moreover, its 3-year median value for Total Debt was $69.0 million (2023), whereas its average is $68.7 million.
  • Per our database at Business Quant, Organogenesis Holdings' Total Debt surged by 40.33% in 2020 and then declined by 8.93% in 2023.
  • Organogenesis Holdings' Total Debt (Quarterly) stood at $76.7 million in 2020, then decreased by 4.23% to $73.4 million in 2021, then declined by 3.62% to $70.8 million in 2022, then dropped by 6.41% to $66.2 million in 2023, then decreased by 8.11% to $62.1 million in 2024.
  • Its last three reported values are $62.1 million in Q3 2024, $63.5 million for Q2 2024, and $64.9 million during Q1 2024.